Plus Therapeutics (PSTV) Cost of Revenue (2011 - 2020)
Plus Therapeutics (PSTV) reported Cost of Revenue of $104000.0 for Q3 2020, up 10.64% year-over-year from $94000.0 in Q4 2019, and down 0.95% quarter-over-quarter from $105000.0 in Q2 2020.
Plus Therapeutics (PSTV) Cost of Revenue (2011 - 2020) Analysis & Trends
Plus Therapeutics (PSTV) has 10 years of Cost of Revenue data on file, last reported at $104000.0 in Q3 2020.
- Cost of Revenue for Q3 2020 came in at $104000.0, up 10.64% year-over-year; the trailing twelve-month figure through Sep 2020 was $482000.0 (up 36.93% YoY), and the FY2019 annual result was $468000.0, down 27.22% from the prior year.
- Cost of Revenue declined to $104000.0 in Q3 2020 per PSTV's latest filing, from $105000.0 in the prior quarter.
- Over five years, Cost of Revenue peaked at $1.3 million in Q2 2017 and troughed at -$1.7 million in Q4 2017.
- A 5-year average of $354894.7 and a median of $163000.0 in 2019 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2017 and 2019: Cost of Revenue tumbled 298.5% in 2017, then soared 246.81% in 2019.
- A 5-year view of Cost of Revenue shows it stood at $869000.0 in 2016, then plunged by 298.5% to -$1.7 million in 2017, then soared by 102.72% to $47000.0 in 2018, then soared by 246.81% to $163000.0 in 2019, then slumped by 36.2% to $104000.0 in 2020.
- Business Quant data shows PSTV's Cost of Revenue at $104000.0 in Q3 2020, $105000.0 in Q2 2020, and $110000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 64.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 48,670.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 392.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 2.05 Mn |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 104,000.00 |
| Sep 30, 2020 | 104,000.00 |
| Jun 30, 2020 | 105,000.00 |
| Jun 30, 2020 | 105,000.00 |
| Mar 31, 2020 | 110,000.00 |
| Mar 31, 2020 | 110,000.00 |
| Dec 31, 2019 | 163,000.00 |
| Dec 31, 2019 | 163,000.00 |
| Sep 30, 2019 | 94,000.00 |
| Sep 30, 2019 | 94,000.00 |
| Jun 30, 2019 | 97,000.00 |
| Jun 30, 2019 | 97,000.00 |
| Mar 31, 2019 | 114,000.00 |
| Mar 31, 2019 | 114,000.00 |
| Dec 31, 2018 | 47,000.00 |
| Dec 31, 2018 | 47,000.00 |
| Sep 30, 2018 | 118,000.00 |
| Sep 30, 2018 | 118,000.00 |
| Jun 30, 2018 | 185,000.00 |
| Jun 30, 2018 | 185,000.00 |